Cognetivity Neurosciences Ltd
CNSX:CGN
Balance Sheet
Balance Sheet Decomposition
Cognetivity Neurosciences Ltd
Cognetivity Neurosciences Ltd
Balance Sheet
Cognetivity Neurosciences Ltd
| Jan-2016 | Jan-2017 | Jan-2018 | Jan-2019 | Jan-2020 | Jan-2021 | Jan-2022 | Jan-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Short-Term Investments |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
4
|
1
|
1
|
2
|
2
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+1 042%
|
4
+5 381%
|
1
-81%
|
1
+4%
|
2
+144%
|
2
+10%
|
3
+41%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
6
|
11
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
+118%
|
0
-35%
|
1
+327%
|
1
-5%
|
8
+696%
|
13
+66%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
2
|
5
|
7
|
10
|
13
|
16
|
|
| Retained Earnings |
0
|
1
|
2
|
5
|
7
|
9
|
19
|
26
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
3
N/A
|
0
-86%
|
0
N/A
|
1
N/A
|
6
N/A
|
10
-74%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+1 042%
|
4
+5 381%
|
1
-81%
|
1
+4%
|
2
+144%
|
2
+10%
|
3
+41%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
41
|
30
|
25
|
43
|
49
|
70
|
79
|
85
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
|